In order to drive productive tumor-infiltrating lymphocyte (TIL) function, myeloid populations must direct antigens to the lymph node, including to resident antigen-presenting cells (APCs) that have never touched the tumor. It has long been supposed that APCs trade antigens with one another, but the dominant cell biology underlying that remains unknown. We used in vitro and in vivo assays together with lattice light sheet and multiphoton imaging to show that myeloid cells carry tumor antigen-laden vesicles that they 'trade' with one another as they reach distant sites. This accounts for the majority of antigen displayed to T cells and provides tumors with a mechanism to access APCs that differentially direct T cell activation away from memory phenotypes. This work defines efficient cell biology that drives the first steps of TIL generation and represents a new frontier for engineering tumoral immunity.
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Main Text:
Immune responses to cancer require the movement of tumor-derived antigens into the tumor draining lymph node (tdLN) where T cell priming takes place on a diverse set of dendritic cell (DC) populations. Previous work has shown that migratory DC populations are required to carry tumor antigens to the tdLN and more broadly to disseminate tumor antigens to tdLN resident DC populations, but the biological mechanism for this has been unclear (1) . Peptides injected in the context of vaccination can directly drain to the LN for sampling by resident myeloid cells (2, 3) whereas migratory cells are required to carry antigen to the LN in other physiological challenges such as infection or tolerance, and the antigens are then subsequently acquired by resident DC (4) (5) (6) (7) (8) (9) (10) . In the context of an actively growing tumor, much less is known; competing hypotheses from other systems suggest migratory DC may: 1. Undergo apoptosis and be taken up by resident cells (7) ; 2. Secrete exosomes containing antigen for subsequent stochastic re-uptake(11); 3. Secrete soluble antigens into the LN interstitium (12) or 4. Transfer entire peptide-MHC complexes, in a process termed cross-dressing and likely most important for memory T cell activation (13) .
To track dissemination of tumor proteins, B16F10 cells were modified to express the pH-stable fluorophore ZsGreen (B16ZsGreen), a fluorophore that persists much longer than others in intracellular compartments and allows long-term optical tracking of proteins (1) . These tumors were then grown in mice expressing membrane bound tdTomato (mT) on all host cells ( Fig. 1A) and both the tumor and the draining lymph node (tdLN) were examined. This revealed that host cells in the tumor microenvironment (TME) contained significant quantities of tumor-derived ZsGreen, and this material was consistently observed as vesicular puncta ( Fig. 1A) and never as uniform cytoplasmic distributions. By flow cytometry, digested B16ZsGreen tumors showed significant ZsGreen uptake by host CD45 + cells ( Fig. 1B) and uptake was penetrant: 100% of tumor associated macrophages (TAMs) and conventional dendritic cell (DC) type 1 (cDC1) and type 2 (cDC2) and ~60% of monocytes contained significant amounts of ZsGreen (Fig. 1C, see Fig. S1 for gating strategy). To further analyze these vesicles and to determine whether this ZsGreen + compartment accurately represented the localization of germline-encoded tumor antigens in these cells, ZsGreen + myeloid cells were sorted from the TME, stained for melanoma tumor-associated antigens, gp100 and tyrosinase, and imaged by confocal 3 microscopy ( Fig. 1D) . These known tumor antigens were also packaged as discreet puncta, consistent with vesicles. Importantly, within the TME, >75% of ZsGreen containing vesicles contained at least one of these tumor antigens ( Fig. 1D) . For the remainder, we noted that gp100 and tyrosinase are typically located within vesicles in the tumor cells and therefore may be variably distributed after sampling, as compared to cytosolic ZsGreen. We conclude that the host compartment containing ZsGreen also faithfully reports other tumor antigens.
When we used conventional confocal imaging to examine mT + host tdLNs, ZsGreen was again observed within cells as puncta ( Fig. 1E) . We rarely observed ZsGreen material that was not within these intracellular vesicles ( Fig. 1F, S2) and no accumulation was observed in the subcapsular sinus where microparticles would be expected to accumulate (Fig. S2) . The frequency of cells that were ZsGreen + in the tdLN was only about 40% of both migratory and resident cDC1 (migratory CD103 + DC and resident CD8α + DC) and cDC2 (migratory CD11b + DC and resident CD11b + DC), as compared to nearly 100% in the tumor (Fig. 1C, G) . Particularly in mice bearing very large tumors, we often also found plentiful ZsGreen + monocytes but again only identified relatively small numbers of cell-free ZsGreen + subcellular sized microparticles (defined as lacking nuclei and weakly scattering by flow cytometry) ( Fig. 1G) . We sorted cells from the tdLN and analyzed them live, by highresolution lattice light sheet microscopy (LLS) in order to resolve the puncta and minimize background fluorescence. All of the detectable ZsGreen signal localized to vesicular structures (ZsGreen signal surrounded by mT + membrane shown in Fig. 1H , image rendering (right) highlights ZsGreen puncta membrane encapsulation by showing 3D depth in z (cell volume, grey) see also Movie S1). As in cells derived from the TME, the majority of ZsGreen + puncta, including those in resident DC populations, also contained the other canonical tumor-associated antigens, again suggesting a common vesicular compartment for internalized antigen (Fig. 1I) .
In previous studies using genetically deficient mice and also confirmed with mixed bone marrow chimera experiments, CCR7 was shown to be required for DC migration from the tumor to the tdLN and for the subsequent ability to activate T cells (1, 14) . We extended that finding here, showing that ZsGreen + cells and 4 microparticles were virtually absent in the tdLN of Ccr7 -/mice ( Fig. S3A) . In contrast, in mice lacking CCR2, a chemokine required for monocyte migration, ZsGreen levels were comparable to controls (Fig. S3B) . In wildtype animals, detailed study of ZsGreen levels in migratory DC of the tdLN demonstrated a 10-fold reduction in fluorescence intensity as compared to tumor-resident counterparts ( Fig. 2A) . Likewise, ZsGreen + vesicle number per cell in the migratory DC decreased by over half when looking at migratory DC in the tdLN compared to the tumor (Fig. S3C) . Furthermore, ZsGreen + resident DC were more numerous and of comparable brightness to migratory DC in the tdLN (Fig. 2B) . These observations are consistent with a fixed amount of fluorescence being actively redistributed, as vesicular packets, into a larger number of recipient cells in the tdLN. Thus, we considered the possibility of directed handoff to resident cells, leading to the dilution of the fluorescence in migratory populations. Such a mechanism would represent the cellular equivalent of the ancient mancala 'sowing' games in which rules determine how and when 'seeds' are moved from one players compartments into the compartments of another.
Consequently, we developed an in vitro 'mancala assay' wherein in vivo-loaded ZsGreen + 'donor' DC from tdLN were incubated with nuclear tdTomato (nT) + 'recipient' DC. After 16 hours, we used flow cytometry to determine whether, and under what conditions, tumor-derived material transferred from one cell type to another ( Fig. 2C) . Using a single type of recipient cell, we observed a pattern wherein either population of migratory DC served as an equally proficient donor and cDC1-especially resident CD8α + DC-were consistently the best recipients ( Fig. 2D) . In our assays, we found that all populations formed contacts at similar levels with donors, as assessed by measuring doublets, suggesting that it was the actual transfer and not a contact-event that was regulated ( Fig. S4A-B) . We also performed a competitive version of the mancala assay, in which all four recipient cell types were present in the same well, to assess dominance. Here, there was less consistency in terms of which donor cell type produced the highest degree of transfer, but the resident cDC1 CD8α + DC always ultimately accumulated the majority of the material, thus serving as the best recipient, by the conclusion of the assay ( Fig. 2E) . While both the individual and the competitive mancala assays ordained the CD8α + DC the superior recipient in vitro, this may be tempered in vivo where the localization and number of particular DC subsets likely play a role and we indeed see resident CD11b + DC as active participants in tumor antigen 5 uptake in vivo (Fig. 2B) . Beyond the cellular level, we next used this assay to more completely address the vesicular nature of the 'passed' antigen. To do this, we performed the mancala assay using ZsGreen-loaded DC sorted from the LN of mT + mice bearing B16ZsGreen tumors. The ZsGreen + ,mT + DCs were co-cultured with unlabeled, naïve, congenically marked, recipient DC ( Fig. S5A) . After 16hr, the CD45.1 + ZsGreen + recipient DCs were sorted, cell surface-stained with anti-CD45 and imaged by LLS. The high-resolution imaging revealed intracellular ZsGreen + puncta enveloped by donor DC mT + membrane demonstrating that passed antigen is handed off to the recipient DC in packets, likely the vesicles themselves ( Fig. S5B) .
Next, we varied the mancala assay to provide insight into mechanism. First, we found that the entire process of transfer was abrogated when populations were separated by a transwell (Fig. 2F) suggesting, but not proving, that antigen is not passed in soluble form nor in exosomes in this system, in agreement with previously published data using in vitro generated bone marrow derived dendritic cells (BMDC) (15) . We next applied a pharmacological perturbation. Here, we eliminated migratory cDC1 from the recipient pool as they were previously determined to be poor recipients and furthermore were more difficult to purify in sufficient numbers for this assay. Amongst many inhibitors tested, we found that PI3K class I (GDC0941) or III (VPS34-IN1) inhibition, which prevents phagocytosis, strongly inhibited CD8α + cDC1 uptake, and produced less pronounced effects on the other recipient types ( Fig. S6A-B ). CD8α + DC have been previously described as being more phagocytic than cDC2, perhaps also explaining their dominance in antigen uptake in vitro (Fig 2E) (9, 16, 17) .
Overall, this suggests that different DC may rely on different mechanisms for antigen uptake.
We also applied this assay to specifically interrogate the role of DC apoptosis in antigen transfer. We first added zVAD, which blocks caspase activity, and saw no effect on transfer for any combination (Fig. 2G) despite increases in survival of donor DC subsets ( Fig. 2H) . However, unlike the BMDC used in previous studies, DC from tdLN showed low rates of apoptosis overall suggesting that high rates of DC death both in vitro and in vivo may not represent a prominent source of antigen transfer for in vivo DC populations ( Fig. 2I) .
Given that transwells blocked antigen transfer, we explored the hypothesis that vesicle transfer required direct cell-cell contact. To date, myeloid-myeloid interactions have not been well documented and so we devised a 6 real-time, 2-photon, imaging strategy to study these in the interfollicular T cell zone of the tdLN of mice bearing B16ZsGreen tumors. To do this in live, excised, lymph nodes, we used mice bearing a combination of XCR1-Venus(18), CD11c-mCherry (19) and MacBlue (20) transgenes. These alleles were chosen as they largely discriminate key populations under study here, namely: Venus + mCherry + = cDC1, mCherry + = cDC2, CFP + = monocytes and a fraction of mCherry + CFP + = resident cDC2 (Fig. 3A, Fig. S7 ). These cells are in constant, albeit slow, motion within the lymph node; we measured the duration of engagements, defined as the edge of the fluorescence of one cell type within 1μm of another ( Fig. 3A) (21) . We then plotted the lifetimes of the interactions (Fig. 3B) . The time of interaction between populations was best modeled by a two-phase exponential decay. The first phase for all contact pairs had a T 1/2 of <60s, likely representing cells passing one another ( Fig. 3B) . The second phase only occurred in about 20% of the contacts between two DC and demonstrated a much longer T 1/2 of approximately 240s with durations that could extend beyond 10 minutes ( Fig. 3B-C) . This suggested that, at times, DC might engage in more substantial communication with one another. Of note, only ~5% of monocyte:DC contacts endured into the second phase of decay ( Fig. 3B-C) .
To examine the details of such DC-DC interactions, we used high-resolution, real-time, LLS in vitro (21) . When we separated and rotated these synapses, we found that both cells faced one another 'cup-on-cup' (i.e. each membrane concave in the center of the contact). In one rare example, we also found a finger-like projection protruding into the cup (Fig. S8B) .
The sum of the LLS studies show that when DC contact one another, they initially probe with veils of membrane but can further engage in more persistent close membrane-membrane juxtapositions ( Fig. 3D-F,   Fig. S8, Movie S2-4) . Notably, the active synapses also showed evidence of exchange of both vesicular material and membranes (arrows in Fig. 3F, Movie S5, Fig. S9 ).
We thus hypothesized that these synapses might represent the structure for cell-to-cell tumor antigencontaining vesicle transfer. To investigate the outcome of these interactions we first imaged the in vitro mancala assay from Fig. 2E (Fig. 3G) , now using a conventional confocal microscope with a wider field of view. We took time-lapse movies of a single type of transfer-from the typically dominant migratory CD103 + cDC1, into the resident CD8α + population. Antigen loaded CD103 + DC were observed forming contacts and then transferring a portion of their ZsGreen cargo into the recipient, in the absence of a secreted intermediate ( Fig. 3G, Movie S6) . Antigen transfer occurred on timescales consistent with the 2 nd phase observed in vivo, typically occurring within approximately 300s after contact formation ( Fig. 3H) . Transfer overall was rare, occurring in <1% of contacts in the typical 8-10 hours of imaging, but was observed in all pairs of migratory donor and a resident recipient (data not shown). We also observed ZsGreen-loaded CD103 + DC passing vesicles sequentially to multiple CD8α + DC (Movie S7) which shows the process can be repeated and that a cell can pass antigen while remaining viable both before and after the passing occurs. In support of synaptic transfer as the dominant mechanism of handoff, antigen acquisition by recipient DC was always observed in the context of contact between cells and never observed as uptake of cell-free/apoptotic debris, in over 48 hours of total imaging (Fig 3I) .
Motivated to examine antigen transfer in vivo, we performed multiphoton microscopy in the interfollicular T cell zone of tdLN of XCR1-Venus; CD11c-Cherry; MacBlue mice bearing B16ZsGreen tumors. An example, shown in Fig. 4A (Movie S8), shows a cDC2 (CD11c-Cherry + ) transfering ZsGreen to a cDC1 (XCR1-Venus + ). As in vitro, overall frequencies of transfer in a typical 30 minute movie was rare, but approximately 75% of the imaging experiments resulted in at least one detectable transfer event, which always occurred at a contact and never via a DC-free exosome or apoptotic body ( Fig. 4B) .
Direct cell contacts would predict a sequential filling of antigens into various myeloid populations as one
directly hands off to others, as opposed to all compartments filling at the same rate. To test this in vivo, we developed a method to pulse tumor material into antigen presentation by generating a B16F10 line initially expressing mCherry which could be induced to express ZsGreen by virtue of the expression of tamoxifen 8 regulated Cre (Fig. 4C) . This tumor line was injected into mice, which were then gavaged with tamoxifen at staggered time points prior to harvest at day 14 post-injection. Tumor and tdLN were then examined for ZsGreen fluorescence (Fig. 4C) . In the tumor, cells acquired ZsGreen with distinct kinetics: neutrophils, monocytes and macrophages became maximally ZsGreen + in near-concert with the tumor itself, maximally by day 5 (Fig. 4D) . Tumor-resident DC loading kinetics were more protracted and maximal loading occurred by day 7 (Fig. 4D) . Although there was greater variability between mice in the tdLN, there was a clear hierarchy wherein only migratory DC populations were significantly loaded at day 3 and continued to increase thereafter ( Fig. 4E) . In contrast, no loading was observed for resident DC until day 5. Finally, monocytes and microparticles (MP) containing ZsGreen were only detected at day 7 (Fig. 4E) . This result is consistent with older work in vaccination models(22) that demonstrated a need for cell-dependent delivery of material to lymph nodes but here is extended to tumor antigens with vesicular hand-off specific myeloid subpopulation kinetics.
To examine whether ZsGreen vesicle passage is required for DC to obtain significant ligands for T cells, we generated B16F10 cells expressing ZsGreen fused to the OTI and OTII OVA peptides (B16ZsGreen-minOVA).
This allowed for initial flow-sorting of otherwise similar DC into ZsGreen + versus ZsGreensubsets and then permitted us to test which population could stimulate T cells ( Fig. 4F-G and Fig. S10A-C) . This revealed that only DC marked by detectable ZsGreen levels could stimulate OTI T cells, regardless of subset ( Fig. 4G, Fig.   S10B ). If other methods of antigen-transfer were dominant, we could expect that both populations would stimulate similarly. We may conclude that other mechanisms that do not accompany such transfer are relatively ineffective sources of ligands. While it is possible that pre-loaded pMHC is acquired concurrently with bolus antigen, work by others has shown cross-dressed DCs are only effective in stimulating resting memory T cells, and are unable to activate a naïve population (17) . It may thus be that low levels of membrane-only transfer is sufficient to trigger highly activated T cells but would likely have less importance for naïve T cell priming.
The ability to track antigens into specific recipient DC has further consequences for understanding diversification of T cell response. Previous reports from our lab and others, that did not isolate the exact cells 9 bearing bolus antigen, had concluded that migratory CD103 + cDC1 were unique in their ability to profoundly stimulate anti-tumor CD8 + T cells (1, 14) . However, when ZsGreen antigen-bearing cells were selectively purified, we now also observed stimulatory capacity for resident CD8α + DC and migratory CD11b + DC ( Fig.   4G ). (CD4 + OTII cells were stimulated most efficiently by ZsGreen + migratory CD11b + DC as previously reported(23) (Fig. S10C) ). Beyond revealing the undocumented CD8 + T cell stimulatory capacity of migratory CD11b + and resident CD8α + DC, the selection of antigen-bearing DC also now allowed direct ex vivo analysis of the induction of distinct effector programs by DC subsets. It has previously been reported that different DC can drive T cells to differentiate in distinct ways during infection (24) and following acquisition of dying selfcells (25) , but heretofore, has not been shown in the tdLN. Comparing RNA expression from T cells following stimulation with the three proliferation-driving DC subsets demonstrated that the ZsGreen vesicle + , CD8α + DC, drove the most transcriptionally distinct outcome, with 291 genes consistently differentially regulated by CD8α + DC compared to both CD11b + DC and CD103 + DC (Extended Data Fig. 8d-e ). These genes were enriched in signature GO terms relevant to immune function comprising genes involved in interferon responses, cell division and T cell mediated cytotoxicity ( Fig. S10D, Fig. S11) . By comparing the gene expression profiles to previously defined molecular signatures (26, 27) , we find that cells stimulated via resident CD8α + DC show reduced responses to IFNγ pathway induction and memory induction and increased modules associated with short term effectors ( Fig. S12) . Specific distinctions in RNA were confirmed at the protein level, demonstrating specific decreases in PD1 expression following priming via migratory CD11b + DC ( Fig. S10F-G) , increased CD69 expression when stimulated by CD103 + DC ( Fig. 4H-I ) and the combination of decreased CD127 and increased KLRG1 (Fig S10G, as a ratio in Fig 4J-K) when triggered by antigen-positive CD8α + DC. The latter is once again significant for antigen handoff since a skewed ratio of these genes is associated with the formation of short-term effector subsets in other systems (28) and thus tumor loading of these cells would skew away from memory phenotypes, which are thought to be more capable of tumor rejection (29, 30) .
Studies of tdLNs in human melanoma patients have observed vesicles, similar to those we described here, inside myeloid populations termed 'melanophages' (31, 32) . While other mechanisms, not observed in this study, may provide additional antigens to T cells, our data clearly supports that specific and contained vesicles of antigen are a robust mechanism for antigen handoff, leading to tdLN priming and potentially contributing to tumor tolerance. The 'mancala' handoff mechanism moves this field well beyond 'trogocytosis' (33) , defined as the nibbling of one cell by another, insofar as this vesicle delivery is the very deliberate transfer of a discrete 'packet' of material which is highly enriched in material from an original donor. And while "cross-dressing" defined as movement of intact peptide-MHC complexes and important for memory T cell activation (17) may happen independently, contemporaneously or subsequent to the vesicular exchanges we've identified here, our results positively correlate cells containing these vesicles with the ability to stimulate naïve T cells. It may be that the vesicles transferred carry information, beyond the antigens themselves, that are instructive to myeloid cells and the synapses described in this study presumably provide additional opportunities for the immune system to self-align. Further studies will need to define how these vesicles are initially programmed at the tumor or elsewhere; options including via nibbling of live cells, processing of dead debris or ingestion of pre-formed exosomes. The possible role of these vesicles for transfer of non-self commensals and pathogenderived will also be important. Referencing the two-signal model of T cell activation-wherein signal 1 (TCR-pMHC signaling) is complemented by signal 2 (CD28, and opposed by CTLA-4 and PD1 checkpoints)manipulation of this transfer biology, affecting which cell type presents signal 1 and how much signal 1 it presents should represent an excellent orthogonal strategy to checkpoint blockade therapies, to license or augment therapeutic benefits.
Materials and Methods
Mice. Mice were housed and bred under specific pathogenfree conditions at the University of California, San Francisco Laboratory Animal Research Center and all experiments conformed to ethical principles and guidelines approved by the UCSF Institutional Animal Care and Use Committee. C57BL/6 mice were purchased from Jackson Laboratory or bred in house, and unless otherwise noted animals used were male between 6-8 weeks of age. C57BL/6 were used for all ectopic tumor studies. Ccr7-deficient C57BL/6 mice, purchased from Jackson Laboratory, were used for modulation of tumor-associated DC migration studies (34) .
The mTmG reporter strain (35) was maintained both as a single transgenic and also crossed with a βactin-Cre line (Jackson Laboratory) to achieve mG mice. nTnG mice were purchased from Jackson Laboratory. Ccr2-deficient C57/BL6 mice were purchased from Jackson Laboratory. XCR1-Venus (18) mice were crossed with CD11c-mCherry (Jackson Laboratory) and MacBlue (Jackson Laboratory) reporter mice to achieve the triple reporter mouse line. OTI and OTII mice were purchased from Jackson Laboratory and then crossed with CD45.1+ congenic mice for use as T cell donors in the T cell stimulation assays. CD45.1 mice were obtained from Jackson Laboratory.
Cell lines and ectopic tumor injections. Briefly, adherent cells were cultured at 37°C with 5% CO 2 in DMEM (GIBCO) plus 10% heat-inactivated FCS with penicillin, streptomycin and L-glutamate on tissue culture-treated plastic plates and split every other day. B16ZsGreen, B16 melanoma parental cells were genetically engineered to stably express ZsGreen using viral transduction with a ZsGreen construct. Inducible B16ZsGreen, B16 melanoma parental cells were genetically engineered to stably express both a Thy1.1-CreER T2 construct and a loxP-mCherry-loxP-ZsGreen construct using viral transduction of both expression vectors and selection for stable integrants using an Aria II cell sorter and detection of mCherry and Thy1.1 coexpressing cells. B16zsGreen-minOVA, B16 melanoma parental cells were genetically engineered to stably express ZsGreen-minOVA using viral transduction with a ZsGreen-minOVA construct. For ectopic tumor injections, cells were grown to confluency, harvested and washed 2 times with PBS, mixed at a 1:1 ratio with growth factor-reduced Matrigel Matrix (BD Biosciences) in a final injection volume of 50ul. Two hundred thousand tumor cells were injected subcutaneously in the right and left flanks of mice and allowed to grow for 14 days before harvest of tumor and lymph node.
Tissue digest and DC isolation. LN were dissected from tumor bearing or WT mice, and cleaned of fat. For tumors, inguinal and axillary LN were taken as tumor draining. LN were digested as previously described (1) . In brief, LN were pierced and torn with sharp forceps in 24-well plates and incubated for 15 min at 37 o C in 1 ml digestion buffer (100 U/ml collagenase A (Roche), 500 U/ml collagenase D (Roche), and 20 ug/ml DNAse I (Roche) in RPMI-1640 (GIBCO)). After the first 15-minute incubation, cells was pipetted up and down repeatedly, and, then returned for a second 15-minute incubation at 37 o C. After digestion, LN were washed with RPMI-1640 (GIBCO) plus 10 % FCS and filtered through 70 um Nytex filters before staining for flow cytometry. When sorting from LN, cells were stained with biotin-conjugated anti-CD2 (clone RM2-5, BioLegend) antibody and negative selection was performed by using an EasySep Biotin Selection Kit (Stemcell Technologies) following manufacturers instructions, before staining. For tumor digests, tumor were isolated and minced prior to 30 minute incubation in 6 mL digestion mix (same as LN above) on a shaker at 37 o C. Imaging. Confocal Imaging: DC populations were sorted (based on the gating strategy in Figure S1A antibody (clone HMB45, BioLegend) used at 1:30 followed by an anti-IgG2a secondary conjugated to Alexa555 (Invitrogen) at a concentration of 1:250. Anti-tyrosinase antibody (clone TA99, BioLegend) was used at 1:50 followed by an anti-IgG1 secondary conjugated to Alexa647 (Invitrogen) at a concentration of 1:250. The inverted microscope system is encased within an incubator for live-cell imaging overnight. For whole tissue imaging of LN and tumor, methods for fixing and clearing tissues were performed as previously described(36).
Tissues were then imaged using a Nikon A1R laser scanning confocal microscope using NIS-Elements software. Data analysis was performed using the Imaris software suite (Bitplane). LLS: LLS imaging was performed in a manner previously described (21) . Briefly, 5 mm diameter round coverslips were cleaned by a plasma cleaner, and coated with 2 μg/ml fibronectin in PBS at 37°C for 1 hour before use. Sorted DC were dropped onto the coverslip and incubated at 37°C, 5% CO 2 for 20-30 min. The LN explant imaging of in vivo antigen transfer. Imaging was performed as previously described (38).
Inguinal and axillary LN were removed, cleaned of fat, and immobilized on a plastic coverslip with the hilum facing away from the objective. LN were imaged in 30-minute intervals on a two-photon microscope as per above.
In vitro antigen transfer assays. Recipient nT + DC were isolated and sorted as described above from LN of T cell stimulation assays. OT1 and OTII T cells were isolated from LN of TCR transgenic mice using either a CD8 or CD4 StemSep enrichment kit (STEMCELL Technologies), respectively. DC were obtained through sorting from the dLN of B16zsGreenminOVA bearing mice as described above for B16zsGreen tumor dLN. DC were sorted as either ZsGreen + or ZsGreenfor each of the 4 DC subsets and subsequently used for T cell stimulation. Stimulation assay was performed as previous described (1) . Dilution of cell permeable dye eFluor670 (eBioscience) and expression of CD44 (IM7, BioLegend) were used as indicators of T cell stimulation.
RNA-sequencing
STAR 2.4.2a was used to align reads to the Mus Musculus genome, version GRCm38.78. Only mapped reads uniquely assigned to the mouse genome were used for differential expression testing. These were imported into R and then converted to normalized read counts with DESeq2. QC plots were created from the counts generated by DESeq2's variance Stabilizing Transformation (with blind=True). Differential Expression was performed using DESeq2, and significant genes were filtered by a q-value (False Discovery Rate) threshold of 0.05, and a p-value threshold of 0.05. pheatmap was used for correlation heatmaps, and heatmap.2 for the QC heatmap. Additionally, gene ontology (GO) analysis was performed using the publically available resource from the GO Consortium and the generated RNA-sequencing data. 
